Veritas Asset Management LLP

Institutional investor · Portfolio as of Q2 2026

Top Holdings21 positions

Checking export access…
Activity:
AMZN

Amazon.com, Inc.

2.3M$543.4M9.8%$144.26+73.78%
20 qtrssince 2021-Q3
Decreased
0
MA

Mastercard Incorporated

995,345$511.2M9.2%$386.37+67.50%
26 qtrssince 2020-Q1
Decreased
0
CP

Canadian Pacific Kansas City Limited

5.7M$496.3M8.9%$78.90+15.63%
13 qtrssince 2023-Q2
Decreased
0
AON

Aon plc

1.4M$467.1M8.4%$315.32+4.71%
10 qtrssince 2024-Q1
Decreased
0
UNH

UnitedHealth Group Incorporated

1.1M$448.1M8.1%$315.55+28.17%
30 qtrssince 2019-Q1
Decreased
0
TMO

Thermo Fisher Scientific Inc

882,873$442.6M8.0%$439.98+58.72%
30 qtrssince 2019-Q1
Increased
64
MSFT

Microsoft Corporation

1.1M$422.1M7.6%$303.75+71.52%
30 qtrssince 2019-Q1
Decreased
0
SPGI

S&P Global Inc.

830,609$338.3M6.1%$384.43+21.22%
1 qtr
New
97
WAT

Waters Corporation

851,624$319.4M5.7%——
4 qtrssince 2025-Q3
Decreased
0
VMC

Vulcan Materials Company

1M$306.6M5.5%$294.46-3.35%
1 qtr
New
96
H

Hyatt Hotels Corporation

1.3M$257.1M4.6%$157.92+17.43%
4 qtrssince 2025-Q3
Decreased
0
ICE

Intercontinental Exchange Inc.

2M$244.2M4.4%$110.06+55.31%
29 qtrssince 2019-Q2
Decreased
0
BDX

Becton, Dickinson and Company

1.4M$210.9M3.8%——
26 qtrssince 2020-Q1
Decreased
0
TDG

Transdigm Group Incorporated

137,969$183.8M3.3%$1,329.91-9.16%
3 qtrssince 2025-Q4
Increased
59
SYK

Stryker Corporation

533,784$168.1M3.0%$313.85-1.05%
1 qtr
New
85
ELV

Elevance Health, Inc.

428,672$165.8M3.0%$420.76-1.67%
13 qtrssince 2023-Q2
Decreased
0
PM

Philip Morris International Inc

51,387$9.3M0.2%$62.83+231.08%
30 qtrssince 2019-Q1
Decreased
0
CRM

Salesforce, Inc.

51,741$8.1M0.1%$258.61-14.08%
8 qtrssince 2024-Q3
Decreased
0
OTIS

Otis Worldwide Corporation

105,652$7.6M0.1%$71.17+7.94%
1 qtr
New
46
MDT

Medtronic plc.

96,690$7.6M0.1%$87.11+13.51%
18 qtrssince 2022-Q1
Decreased
0
$5.6B
AUM
21
Positions
Q2 2026
Filing
HI rating · 5.0/5
Quarterly 13F Value Change
Reported 13F value ($B)
Reported 13F values and quarter-over-quarter reported value changes; not investment returns.
QuarterReported value in US dollarsReported value change
2025-Q1$9,900,627,885-7.68399101002%
2025-Q2$9,995,649,8960.959757422496%
2025-Q3$9,360,322,001-6.3560438952%
2025-Q4$9,772,914,1094.40788370268%
2026-Q1$5,903,025,860-39.5980994598%
2026-Q2$5,559,377,741-5.82155875902%
Activity profile
$ moved · Q2'26
New37%Increased2%Decreased43%Exited18%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 4.0 years
<1Q14%1-4Q14%1-2Y5%2Y+67%

Veritas Asset Management LLP manages $5.6B across 21 positions as of Q2 2026. Top holdings: AMZN (9.8%), MA (9.2%), CP (8.9%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 5/5.0.

Q2 2026 Summary

Added SPGI, VMC, SYK and 1 more; exited CHTR, ZTS, MSM and 1 more; increased 2, led by TMO (+36,878 shares); trimmed 15, led by CRM (−2.2M shares). Top move: SPGI (NEW, conviction 97). Portfolio: $5.6B across 21 positions.

Top holdings by portfolio weight

Total AUM$6B
AMZN9.78%
MA9.20%
CP8.93%
AON8.40%
UNH8.06%
TMO7.96%
MSFT7.59%
SPGI6.08%
WAT5.75%
VMC5.52%
Other4.62%

Portfolio allocation by GICS sector

Sectors7
Healthcare31.70%
Financial Services28.07%
Consumer Cyclical14.40%
Industrials12.37%
Technology7.77%
Basic Materials5.52%
Consumer Defensive0.17%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Healthcare, Financial Services, Consumer Cyclical
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Elite(5.0 / 5.0)
Holdings P&L82
Conviction69
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Famous Investors' Portfolios

What the most-followed managers hold, and what they bought and sold each quarter.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used